Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making

Detalhes bibliográficos
Autor(a) principal: Rebar Ali Mohammed
Data de Publicação: 2023
Outros Autores: Bushra Hassan Marouf
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
DOI: 10.1590/s2175-97902022e201095
Texto Completo: https://www.revistas.usp.br/bjps/article/view/207450
Resumo: A collaborative physician-pharmacist relationship is a fundamental component of a patient’s primary care. The aim of this study was to investigate the attitude of physicians toward collaborative work with community pharmacists in Sulaimani City, Iraq. A cross sectional design was utilized, and a questionnaire was sent to 60 physicians, of whom 47 completed the questionnaire. A total of 26 (55.3%) physicians stated that they had a history of collaboration with pharmacists in their routine daily work. During/before the treatment process, more than one-third of the physicians “rarely” practiced collaboratively, and one-fifth “never” collaborated. There was little agreement on the community pharmacist’s recommendations; however, after the treatment decision by the physician, a higher degree of agreement was reported, and the number of physicians who were “rarely” or “never” practiced collaboratively decreased to less than 5%. Furthermore, the physicians’ perspective on the pharmacists’ role showed that advising patients on drug administration (85.1%) and preventing drug interactions (76.6%) were the most common duties of the community pharmacists. Physicians agreed on several barriers with respect to collaboration with pharmacists. In conclusion, the physicians’ perspective on the engagement of the community pharmacist in the management of patients was relatively limited. The pharmacist’s recommendation was more accepted after medications were prescribed than before or during decision making on the treatment.
id USP-31_65baf9662d1b682d53276750fc5bc282
oai_identifier_str oai:revistas.usp.br:article/207450
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
spelling Physicians’ attitude towards community pharmacists’ contribution in the treatment decision makingPhysicianAttitudeCollaborationCommunity pharmacistA collaborative physician-pharmacist relationship is a fundamental component of a patient’s primary care. The aim of this study was to investigate the attitude of physicians toward collaborative work with community pharmacists in Sulaimani City, Iraq. A cross sectional design was utilized, and a questionnaire was sent to 60 physicians, of whom 47 completed the questionnaire. A total of 26 (55.3%) physicians stated that they had a history of collaboration with pharmacists in their routine daily work. During/before the treatment process, more than one-third of the physicians “rarely” practiced collaboratively, and one-fifth “never” collaborated. There was little agreement on the community pharmacist’s recommendations; however, after the treatment decision by the physician, a higher degree of agreement was reported, and the number of physicians who were “rarely” or “never” practiced collaboratively decreased to less than 5%. Furthermore, the physicians’ perspective on the pharmacists’ role showed that advising patients on drug administration (85.1%) and preventing drug interactions (76.6%) were the most common duties of the community pharmacists. Physicians agreed on several barriers with respect to collaboration with pharmacists. In conclusion, the physicians’ perspective on the engagement of the community pharmacist in the management of patients was relatively limited. The pharmacist’s recommendation was more accepted after medications were prescribed than before or during decision making on the treatment.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-01-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20745010.1590/s2175-97902022e201095Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/207450/197580Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRebar Ali MohammedBushra Hassan Marouf2023-08-28T18:55:59Zoai:revistas.usp.br:article/207450Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-08-28T18:55:59Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
title Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
spellingShingle Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
Rebar Ali Mohammed
Physician
Attitude
Collaboration
Community pharmacist
Rebar Ali Mohammed
Physician
Attitude
Collaboration
Community pharmacist
title_short Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
title_full Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
title_fullStr Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
title_full_unstemmed Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
title_sort Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
author Rebar Ali Mohammed
author_facet Rebar Ali Mohammed
Rebar Ali Mohammed
Bushra Hassan Marouf
Bushra Hassan Marouf
author_role author
author2 Bushra Hassan Marouf
author2_role author
dc.contributor.author.fl_str_mv Rebar Ali Mohammed
Bushra Hassan Marouf
dc.subject.por.fl_str_mv Physician
Attitude
Collaboration
Community pharmacist
topic Physician
Attitude
Collaboration
Community pharmacist
description A collaborative physician-pharmacist relationship is a fundamental component of a patient’s primary care. The aim of this study was to investigate the attitude of physicians toward collaborative work with community pharmacists in Sulaimani City, Iraq. A cross sectional design was utilized, and a questionnaire was sent to 60 physicians, of whom 47 completed the questionnaire. A total of 26 (55.3%) physicians stated that they had a history of collaboration with pharmacists in their routine daily work. During/before the treatment process, more than one-third of the physicians “rarely” practiced collaboratively, and one-fifth “never” collaborated. There was little agreement on the community pharmacist’s recommendations; however, after the treatment decision by the physician, a higher degree of agreement was reported, and the number of physicians who were “rarely” or “never” practiced collaboratively decreased to less than 5%. Furthermore, the physicians’ perspective on the pharmacists’ role showed that advising patients on drug administration (85.1%) and preventing drug interactions (76.6%) were the most common duties of the community pharmacists. Physicians agreed on several barriers with respect to collaboration with pharmacists. In conclusion, the physicians’ perspective on the engagement of the community pharmacist in the management of patients was relatively limited. The pharmacist’s recommendation was more accepted after medications were prescribed than before or during decision making on the treatment.
publishDate 2023
dc.date.none.fl_str_mv 2023-01-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/207450
10.1590/s2175-97902022e201095
url https://www.revistas.usp.br/bjps/article/view/207450
identifier_str_mv 10.1590/s2175-97902022e201095
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/207450/197580
dc.rights.driver.fl_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1822179249934565376
dc.identifier.doi.none.fl_str_mv 10.1590/s2175-97902022e201095